Spots Global Cancer Trial Database for bile duct cancer

Every month we try and update this database with for bile duct cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry.	NCT04937322	Bile Duct Cance... Pancreas Cancer	Interventional ...	18 Years -	Methodist Health System
Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)	NCT02082522	Hilar Cholangio...	Photodynamic th... Stenting proced... Chemotherapy re...	18 Years -	Concordia Laboratories Inc.
Quality Of Life in Patients With Malignant Biliary Obstruction	NCT00579865	Gallbladder Can... Liver Cancer Bile Duct Cance...	questionnaires questionnaires	18 Years -	Memorial Sloan Kettering Cancer Center
Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct	NCT01153750	Advanced or Met...	Glivec	18 Years -	University Hospital Dresden
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms	NCT01640522	Hepatocellular ... Primary Liver C... Bile Duct Cance... Pancreatic Canc... Gallbladder Can... Colorectal Carc... Liver Metastase...	Collaborative C... Enhanced usual ...	18 Years -	University of Pittsburgh
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors	NCT04660929	HER2-positive Adenocarcinoma Bile Duct Cance... Biliary Tract C... Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Duct... Carcinoma, Hepa... Cancer Lung Cancer, No... Carcinoma, Ovar... Carcinoma, Smal... Carcinoma, Squa... Carcinoma, Tran... Colorectal Canc... Esophagogastric... Inflammatory Br... Stomach Neoplas... Malignant Neopl... Ovarian Neoplas... Pancreatic Canc... HER2-positive S... HER2-positive B... HER2-positive G... HER-2 Protein O... HER-2 Gene Ampl... Prostate Cancer Head and Neck C... Endometrial Can... Lung Cancer, Sm...	CT-0508 Pembrolizumab	18 Years -	Carisma Therapeutics Inc
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors	NCT03517488	Melanoma Breast Carcinom... Hepatocellular ... Urothelial Carc... Squamous Cell C... Renal Cell Carc... Colorectal Carc... Non-small Cell ... Gastric or Gast... Endometrial Car... Mesothelioma Neuroendocrine ... Cervical Cancer Small Cell Lung... Squamous Cell C... Castration-Resi... Nasopharyngeal ... Cholangiocarcin... Basal Cell Carc... Ovarian Carcino... Fallopian Tube ... Thymoma Thymic Carcinom... Squamous Cell C... Vulvar Carcinom... Solid Tumors Wi... Malignant Adnex... Non-squamous Ce...	XmAb20717	18 Years -	Xencor, Inc.
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms	NCT01640522	Hepatocellular ... Primary Liver C... Bile Duct Cance... Pancreatic Canc... Gallbladder Can... Colorectal Carc... Liver Metastase...	Collaborative C... Enhanced usual ...	18 Years -	University of Pittsburgh
Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program	NCT03475966	Pancreatic Canc... Liver Cancer Bile Duct Cance... Hepatobiliary C... Surgery	Exercise Nutrition Relaxation tech...	18 Years - 95 Years	McGill University Health Centre/Research Institute of the McGill University Health Centre
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer	NCT01915225	Colorectal Neop... Gastric Neoplas... Cholangiocarcin... Bile Duct Cance... Pancreas Cancer		2 Years -	National Institutes of Health Clinical Center (CC)
T-EUS for Gastrointestinal Disorders: A Multicenter Registry	NCT01522573	Cholangiocarcin... Pancreatic Canc... Bile Duct Cance... Biliary Strictu... Biliary Obstruc... Stent Obstructi... Proximal Duct S... Distal Duct Str... Ampullary Cance... Biliary Sphinct... Impacted Stones Chronic Pancrea... Peri-ampullary ... Altered Anatomy	EUS guided ERCP	18 Years -	Weill Medical College of Cornell University
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6	NCT03058289	Breast Cancer Head and Neck C... Squamous Cell C... Lymphoma Pancreatic Canc... Liver Cancer Colon Cancer Lung Cancer Bile Duct Cance... Chordoma of Sac... Sarcoma	INT230-6 anti-PD-1 antib... anti-CTLA-4 ant...	18 Years -	Intensity Therapeutics, Inc.
Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)	NCT06277531	Biliary Strictu... Bile Duct Cance... Pancreas Cancer		18 Years - 85 Years	Peking University Third Hospital
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene	NCT03602079	HER2-positive B... HER2 Gene Mutat... HER-2 Gene Ampl... HER2 Positive G... Salivary Gland ... Salivary Gland ... Salivary Gland ... Salivary Gland ... Lung Cancer Colo-rectal Can... Rare Diseases Solid Tumor Recurrent Gastr... Recurrent Colon... Recurrent Breas... Head and Neck C... Head and Neck C... Bladder Cancer Cervical Cancer Liver Cancer Bile Duct Cance... Urologic Cancer Pancreatic Canc... Prostate Cancer Recurrent Prost... Rectal Cancer Recurrent Ovari... Recurrent Renal... Rectal Cancer S... Rectal Cancer S... Rectal Cancer S... Skin Cancer Mouth Cancer Lip Cancer Stag... Tongue Cancer Breast Neoplasm... Larynx Cancer Tonsil Cancer Palate Cancer Mucoepidermoid ... Primary Periton... Mucinous Adenoc... Mucinous Breast... Cholangiocarcin...	A166	18 Years -	Klus Pharma Inc.
Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations	NCT04087876	Intrahepatic Ch...	derazantinib	18 Years -	Basilea Pharmaceutica
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders	NCT01438385	Ampullary Cance... Duodenal Cancer Bile Duct Cance... Bile Duct Disor... Gallstones Obstructive Jau... Pancreatic Diso... Colorectal Canc... Esophageal Canc... Barrett's Esoph... Gastric Maligna... Pancreatic Canc... Pediatric Gastr... Cholangiocarcin... Pancreatic Pseu... Acute and Chron... Recurrent Pancr... Cholangitis Bile Leak Biliary Strictu... Pancreatic Divi... Biliary and Pan... Choledocholithi...	Interventional ...	18 Years -	Weill Medical College of Cornell University
Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)	NCT02082522	Hilar Cholangio...	Photodynamic th... Stenting proced... Chemotherapy re...	18 Years -	Concordia Laboratories Inc.
Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma	NCT02128282	Cholangiocarcin...	CX-4945 Cisplatin Gemcitabine	18 Years -	Senhwa Biosciences, Inc.
Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma	NCT01755013	Cholangiocarcin... Biliary Strictu... Biliary Obstruc... Bile Duct Cance...	Photodynamic Th...	18 Years -	Weill Medical College of Cornell University
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)	NCT02821754	Biliary Tract N... Liver Cancer Hepatocellular ... Cholangiocarcin... Bile Duct Cance...	Durvalumab Tremelimumab Trans-arterial ... Radiofrequency ... Cryoablation	18 Years -	National Institutes of Health Clinical Center (CC)
Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy	NCT02853474	Gastric Cancer Pancreas Cancer Bile Duct Cance... Gastroesophagea... Esophageal Canc...	Early Palliativ... EORTC-QLQ-C30 q... HADS score	18 Years -	Centre Oscar Lambret
Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer	NCT01111591	Bile Duct Cance... Pancreatic Canc...	Cox2 inhibitor ...	19 Years - 70 Years	Seoul National University Hospital
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.	NCT04152018	Squamous Cell C... Renal Cell Carc... Ovarian Cancer Gastric Cancer Esophageal Canc... Lung Squamous C... Pancreatic Canc... Bile Duct Cance... Endometrial Can... Melanoma Cancer Urothelial Canc...	PF-06940434 PF-06801591	18 Years -	Pfizer
Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers	NCT00183846	Pancreatic Canc... Gastric Cancer Duodenum Cancer Bile Duct Cance...	irinotecan radiation thera...	18 Years -	University of Southern California
Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis	NCT02841800	Liver Cancer Bile Duct Cance... Pancreatic Canc...	'Intra-luminal ...	20 Years - 75 Years	National Taiwan University Hospital
Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy	NCT00628186	Pancreatic Canc... Bile Duct Cance... Ampullary Cance... Pancreatitis Duodenal Cancer	external draina... internal draina...	-	Wakayama Medical University
Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation	NCT01151761	Cholangiocarcin... Hepatobiliary N... Liver Cancer Bile Duct Cance... Cancer of Gallb...	Stereotactic Bo... Gemcitabine Cisplatin Carboplatin Capecitabine 5FU Liver transplan...	18 Years -	Stanford University
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies	NCT03329950	Melanoma Non-small Cell ... Breast Cancer Gastric Cancer Renal Cell Carc... Ovarian Cancer Cholangiocarcin... Bladder Urothel... Pancreatic Aden... Colorectal Canc... Esophageal Canc... Hepatic Cancer Head and Neck C... Primary Periton... Fallopian Tube ... Other Solid Tum... Diffuse Large B... Mantle Cell Lym... Indolent B-cell... Non-Hodgkin Lym... Follicular Lymp... Lymphoplasmacyt... Waldenstrom's D... Marginal Zone L... Mucosa Associat... Small Lymphocyt...	CDX-1140 CDX-301 pembrolizumab Chemotherapy	18 Years -	Celldex Therapeutics
Loop-tipped Guidewire in Selective Biliary Cannulation	NCT02028845	Choledocholithi... Bile Duct Cance... Pancreatic Canc... Ampullary Tumor	Biliary cannula... Biliary cannula...	20 Years - 90 Years	Ajou University School of Medicine
Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension Study	NCT04924062	Biliary Tract C...	Pembrolizumab Gemcitabine Cisplatin Placebo	18 Years -	Merck Sharp & Dohme LLC
Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer	NCT01096745	Metastatic Bili... Locally Advance...	Gemcitabine, Ci... S-1, Cisplatin	20 Years -	Gyeongsang National University Hospital
Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy	NCT02853474	Gastric Cancer Pancreas Cancer Bile Duct Cance... Gastroesophagea... Esophageal Canc...	Early Palliativ... EORTC-QLQ-C30 q... HADS score	18 Years -	Centre Oscar Lambret
A Study of DB-1303 in Advanced/Metastatic Solid Tumors	NCT05150691	HER2-positive A...	DB-1303 Pertuzumab Inje... Ritonavir Itraconazole	18 Years -	DualityBio Inc.
Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma	NCT06076252	Ampullary Cance... Bile Duct Cance... Pancreas Cancer Duodenum Cancer	Modified Blumga... conventional Bl...	18 Years - 75 Years	Affiliated Hospital of Guangdong Medical University
A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas	NCT01900158	Cholangiocarcin...	Amphinex, Gemci...	18 Years -	PCI Biotech AS
Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).	NCT04566133	Bile Duct Cance... Biliary Cancer Biliary Tract N... Cholangiocarcin...	Trametinib Hydroxychloroqu...	18 Years -	National Institutes of Health Clinical Center (CC)
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio	NCT05655949	Bile Duct Cance... Cholangiocarcin... Cholangiocarcin... Cholangiocarcin... Metastatic Intr...	Gemcitabine Cisplatin Durvalumab Yttrium-90	18 Years -	Beth Israel Deaconess Medical Center
Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy	NCT00628186	Pancreatic Canc... Bile Duct Cance... Ampullary Cance... Pancreatitis Duodenal Cancer	external draina... internal draina...	-	Wakayama Medical University
Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy	NCT01256047	Bile Duct Cance...	Oral IMPACT	18 Years -	Chiba University
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)	NCT06048133	Biliary Tract C... Cholangiocarcin... Bile Duct Cance...	Gemcitabine Cisplatin Zimberelimab Quemliclustat	18 Years -	Big Ten Cancer Research Consortium
Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers	NCT00832637	Hepatocellular ... Cholangiocellul... Cholangiocarcin... Bile Duct Cance... Periampullary A... Gallbladder Can... Extrahepatic Bi...	Cisplatin Erlotinib Gemcitabine	18 Years -	New Mexico Cancer Care Alliance
The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone	NCT04763642	Pancreatic Canc... Bile Duct Cance... Ampulla of Vate...	pancreaticoduod...	21 Years - 80 Years	State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital
Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation	NCT01151761	Cholangiocarcin... Hepatobiliary N... Liver Cancer Bile Duct Cance... Cancer of Gallb...	Stereotactic Bo... Gemcitabine Cisplatin Carboplatin Capecitabine 5FU Liver transplan...	18 Years -	Stanford University
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors	NCT05858736	Melanoma Non Small Cell ... Head and Neck S... High Grade Sero... Primary Periton... Fallopian Tube ... Endometrial Can... Cervical Cancer Renal Cell Carc... Bladder Cancer Esophageal Canc... Gastric Cancer Gastroesophagea... Colorectal Canc... Anal Cancer Hepatocellular ... Bile Duct Cance...	AI-061	18 Years -	OncoC4, Inc.
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry	NCT01439698	Cholangiocarcin... Pancreatic Canc... Bile Duct Cance... Biliary Strictu... Bile Duct Obstr...	Radio Frequency...	18 Years -	Weill Medical College of Cornell University
Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction	NCT00280709	Bile Duct Obstr... Pancreatic Canc... Gallbladder Can... Bile Duct Cance...	"Nitinella" ; S...	20 Years -	University Hospital, Linkoeping
AZD6738 Plus Durvalumab in Biliary Tract Cancer	NCT04298008	Bile Duct Cance... Chemotherapy Ef...	AZD6738 Durvalumab	20 Years -	Seoul National University Hospital
Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma	NCT06175845	Cholangiocarcin... Klatskin Tumor Bile Duct Cance... Liver Cancer	Intraductal bil...	18 Years -	Universitätsklinikum Hamburg-Eppendorf
Quebec Pancreas Cancer Study	NCT04104230	Pancreas Cancer Pancreatic Canc... Pancreas Neopla... Pancreas Cyst Pancreatic Prec... Familial Pancre... Hereditary Canc... Bile Duct Cance... Ampullary Cance... Duodenal Cancer Gallbladder Can...		18 Years -	McGill University Health Centre/Research Institute of the McGill University Health Centre
Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma	NCT04993131	Perihilar Chola... Klatskin Tumor Bile Duct Cance...	Liver transplan...	18 Years -	Oslo University Hospital
A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas	NCT01900158	Cholangiocarcin...	Amphinex, Gemci...	18 Years -	PCI Biotech AS
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors	NCT05712356	Cholangiocarcin... Gallbladder Can... Gallbladder Car... Intrahepatic Ch... Extrahepatic Ch... Bile Duct Cance... Gall Bladder Ca... Gall Bladder Ca...	LSTA1 Durvalumab Cisplatin Gemcitabine FOLFOX regimen Placebo	18 Years -	Lisata Therapeutics, Inc.
Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)	NCT02082522	Hilar Cholangio...	Photodynamic th... Stenting proced... Chemotherapy re...	18 Years -	Concordia Laboratories Inc.
Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)	NCT03111732	Biliary Tract N... Cholangiocarcin... Bile Duct Cance... Liver Cancer Gallbladder Can...	Pembrolizumab (... Oxaliplatin Capecitabine	18 Years -	National Institutes of Health Clinical Center (CC)
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors	NCT04660929	HER2-positive Adenocarcinoma Bile Duct Cance... Biliary Tract C... Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Duct... Carcinoma, Hepa... Cancer Lung Cancer, No... Carcinoma, Ovar... Carcinoma, Smal... Carcinoma, Squa... Carcinoma, Tran... Colorectal Canc... Esophagogastric... Inflammatory Br... Stomach Neoplas... Malignant Neopl... Ovarian Neoplas... Pancreatic Canc... HER2-positive S... HER2-positive B... HER2-positive G... HER-2 Protein O... HER-2 Gene Ampl... Prostate Cancer Head and Neck C... Endometrial Can... Lung Cancer, Sm...	CT-0508 Pembrolizumab	18 Years -	Carisma Therapeutics Inc
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope	NCT06340620	Pancreatic Dise... Pancreatic Canc... Pancreatic Cyst Gastrointestina... Bile Duct Disea... Bile Duct Cance... Lymph Node Dise... Submucosal Tumo... Gastrointestina...	Endoscopic ultr...	18 Years - 100 Years	Orlando Health, Inc.
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	NCT04907643	Cancer Pain Visceral Pain Gastrointestina... Cancer of Gastr... Small Intestine... Pancreas Cancer Liver Cancer Colon Cancer Biliary Tract C... Stomach Cancer Rectum Cancer Peritoneal Canc... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Small Intestine... Small Intestine... Small Intestine... Pancreas Cancer... Pancreas Cancer... Pancreas Cancer... Pancreas Cancer... Liver Cancer St... Liver Cancer St... Liver Cancer St... Liver Cancer St... Colon Cancer St... Colon Cancer St... Stomach Cancer ... Stomach Cancer ... Stomach Cancer ... Rectum Cancer, ... Gastrointestina... Anal Cancer Anal Cancer Sta... Anal Cancer Sta... Anal Cancer Rec... Anal Cancer Met... Anal Cancer, St... Anal Cancer, St... Appendix Cancer Ampullary Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Carcinoid Tumor Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Large Intestine... Esophagus Cance... Esophagus Cance... Esophagus Cance... Esophagus Cance... Gallbladder Can... Gallbladder Can... Gallbladder Can... Gastric (Stomac... Neuroendocrine ... Peritoneum Canc... Rectal Cancer Esophagus Cance... Esophagus Cance... Gallbladder Can... Gallbladder Can... Bile Duct Cance... Bile Duct Cance...	PICO G2 4k	18 Years - 99 Years	Cedars-Sinai Medical Center
Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials	NCT05706974	Bile Duct Cance...		18 Years -	Power Life Sciences Inc.
A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors	NCT05346484	Solid Tumor Solid Carcinoma Solid Tumor, Ad... Metastatic Canc... Advanced Solid ... Cholangiocarcin... Bile Duct Cance...	CF33-hNIS Pembrolizumab	18 Years -	Imugene Limited
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types	NCT05000294	Bile Duct Cance... Gall Bladder Ca... Breast Cancer Neuroendocrine ... Ovarian Cancer Pancreatic Aden... Soft Tissue Sar... Vulvar Cancer Prostate Cancer	Atezolizumab Tivozanib	18 Years - 99 Years	University of Florida
Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers	NCT01134276	Periampullary C... Pancreas Head C... Bile Duct Cance... Ampulla of Vate...	biliary drainag...	20 Years - 85 Years	Seoul National University Hospital
CH-EUS in Diagnosis of Inoperable Bile Duct Tumors	NCT05418543	Inoperable Dise... Bile Duct Cance...	Endoscopic ultr...	18 Years - 99 Years	Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor
Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy	NCT02954302	Pancreatic Canc... Bile Duct Cance... Duodenal Cancer	PrPD with proxi... conventional Pr...	18 Years - 80 Years	The First Affiliated Hospital of Xiamen University
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors	NCT05858736	Melanoma Non Small Cell ... Head and Neck S... High Grade Sero... Primary Periton... Fallopian Tube ... Endometrial Can... Cervical Cancer Renal Cell Carc... Bladder Cancer Esophageal Canc... Gastric Cancer Gastroesophagea... Colorectal Canc... Anal Cancer Hepatocellular ... Bile Duct Cance...	AI-061	18 Years -	OncoC4, Inc.
Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)	NCT04003636	Biliary Tract C...	Pembrolizumab Gemcitabine Cisplatin Placebo	18 Years -	Merck Sharp & Dohme LLC
Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer	NCT06274879	Bile Duct Cance...	Gemcitabin, Cis... Biliary Radiofr... Endoscopic Retr...	18 Years -	Insel Gruppe AG, University Hospital Bern
Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder	NCT02375880	Carcinoma of In... Carcinoma of Ga... Bile Duct Cance... Cholangiocarcin...	DKN-01 gemcitabine cisplatin	30 Years -	Leap Therapeutics, Inc.
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)	NCT02628067	Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc...	pembrolizumab pembrolizumab	18 Years -	Merck Sharp & Dohme LLC
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6	NCT03058289	Breast Cancer Head and Neck C... Squamous Cell C... Lymphoma Pancreatic Canc... Liver Cancer Colon Cancer Lung Cancer Bile Duct Cance... Chordoma of Sac... Sarcoma	INT230-6 anti-PD-1 antib... anti-CTLA-4 ant...	18 Years -	Intensity Therapeutics, Inc.
A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain	NCT04014478	Liver Cancer Pancreas Cancer Stomach Cancer Bile Duct Cance...	Endovascular De...	25 Years - 75 Years	Shanghai Golden Leaf MedTec Co. Ltd
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)	NCT02628067	Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc...	pembrolizumab pembrolizumab	18 Years -	Merck Sharp & Dohme LLC
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry	NCT01439698	Cholangiocarcin... Pancreatic Canc... Bile Duct Cance... Biliary Strictu... Bile Duct Obstr...	Radio Frequency...	18 Years -	Weill Medical College of Cornell University
Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct	NCT01153750	Advanced or Met...	Glivec	18 Years -	University Hospital Dresden
A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)	NCT05849480	Biliary Cancer Bile Duct Cance... Cancer of the B...	oxaliplatin capecitabine Keytruda CDX-1140	18 Years - 120 Years	National Institutes of Health Clinical Center (CC)
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders	NCT01438385	Ampullary Cance... Duodenal Cancer Bile Duct Cance... Bile Duct Disor... Gallstones Obstructive Jau... Pancreatic Diso... Colorectal Canc... Esophageal Canc... Barrett's Esoph... Gastric Maligna... Pancreatic Canc... Pediatric Gastr... Cholangiocarcin... Pancreatic Pseu... Acute and Chron... Recurrent Pancr... Cholangitis Bile Leak Biliary Strictu... Pancreatic Divi... Biliary and Pan... Choledocholithi...	Interventional ...	18 Years -	Weill Medical College of Cornell University
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio	NCT05655949	Bile Duct Cance... Cholangiocarcin... Cholangiocarcin... Cholangiocarcin... Metastatic Intr...	Gemcitabine Cisplatin Durvalumab Yttrium-90	18 Years -	Beth Israel Deaconess Medical Center
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies	NCT03329950	Melanoma Non-small Cell ... Breast Cancer Gastric Cancer Renal Cell Carc... Ovarian Cancer Cholangiocarcin... Bladder Urothel... Pancreatic Aden... Colorectal Canc... Esophageal Canc... Hepatic Cancer Head and Neck C... Primary Periton... Fallopian Tube ... Other Solid Tum... Diffuse Large B... Mantle Cell Lym... Indolent B-cell... Non-Hodgkin Lym... Follicular Lymp... Lymphoplasmacyt... Waldenstrom's D... Marginal Zone L... Mucosa Associat... Small Lymphocyt...	CDX-1140 CDX-301 pembrolizumab Chemotherapy	18 Years -	Celldex Therapeutics
Colonization of Bile Ducts and Postoperative Infectious Complications of Pancreaticoduodenectomies	NCT03525067	Pancreatic Canc... Sepsis Bile Duct Cance... Duodenal Cancer Bile Duct; Obli... Post-Op Complic... Post-Op Infecti... Fistula, Biliar... Fistula Delayed Gastric...	Bile sampling f...	18 Years -	Central Hospital, Nancy, France
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer	NCT01915225	Colorectal Neop... Gastric Neoplas... Cholangiocarcin... Bile Duct Cance... Pancreas Cancer		2 Years -	National Institutes of Health Clinical Center (CC)
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer	NCT01915225	Colorectal Neop... Gastric Neoplas... Cholangiocarcin... Bile Duct Cance... Pancreas Cancer		2 Years -	National Institutes of Health Clinical Center (CC)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: